image: Optical coherence tomography (OCT) can distinguish cancer (red) from non-cancer (green) tissues in in vivo rodent models of human brain cancer and ex vivo fresh human brain cancer specimens with high sensitivity and specificity. This image shows the OCT imaging probe and the 3-D optical property map obtained from a brain cancer patient. This image relates to a paper that appeared in the June 17, 2015, issue of Science Translational Medicine, published by AAAS. The paper, by Dr. Carmen Kut at Johns Hopkins in Baltimore, Md., and colleagues was titled, "Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography." view more
Credit: <i>Science Translational Medicine</i>; Kut C, Chaichana KL, Xi JF, Raza SM, Ye XB, McVeigh ER, Rodriguez FJ, Quinones-Hinojosa A, Li XD